# PHASE 5 — Feature Engineering

## 1. Purpose

Phase 4 gave us:

> **Clean, validated, reproducible, model-ready data.**

Phase 5 now asks:

> **"Can we represent the biomedical information in a way that makes the disease-detection models learn useful patterns more effectively?"**

This is where we **create, transform, and organize meaningful features**.

The most important distinction is:

```text
PHASE 4
Make the data clean.

PHASE 5
Make the representation informative.
```

And because our platform contains a **quantum branch**, Phase 5 must eventually consider both:

```text
Classical representation
        +
Quantum-compatible representation
```

But we should **not yet select the quantum algorithm or number of qubits**. Those decisions belong to later phases.

---

# 2. Position in the System

```text
PHASE 1
Dataset Ingestion & Registration
        ↓
PHASE 2
Dataset Profiling & Discovery
        ↓
PHASE 3
Dataset Validation & Quality Assessment
        ↓
PHASE 4
Preprocessing Pipeline
        ↓
┌──────────────────────────────────────┐
│ PHASE 5                              │
│ FEATURE ENGINEERING                  │
└──────────────────┬───────────────────┘
                   ↓
PHASE 6
Feature Selection & Dimensionality Reduction
```

---

# 3. Core Principle

We should **not blindly generate hundreds or thousands of features**.

Medical datasets can already be high-dimensional.

For example:

```text
Original:
32 features

Feature engineering:
→ 75 features
```

could make the problem worse rather than better.

So Phase 5 needs a controlled process:

```text
Understand features
       ↓
Identify possible transformations
       ↓
Generate candidate features
       ↓
Evaluate usefulness
       ↓
Keep meaningful features
       ↓
Create feature set
```

---

# 4. Input

Phase 5 receives:

```text
dataset_id
+
dataset_profile
+
validation_report
+
preprocessing_pipeline
+
processed dataset
```

Example:

```text
Dataset:
DS-000001

Preprocessing:
PREP-000001

Task:
Binary Classification

Processed features:
32
```

---

# 5. Phase 5 High-Level Flow

```text
                  PROCESSED DATA
                         +
                  DATASET PROFILE
                         |
                         v
              ┌────────────────────┐
              │ Feature Analyzer   │
              └─────────┬──────────┘
                        |
                        v
              ┌────────────────────┐
              │ Domain-Aware       │
              │ Feature Generator  │
              └─────────┬──────────┘
                        |
                        v
              Candidate Features
                        |
                        v
              ┌────────────────────┐
              │ Feature Quality    │
              │ Evaluation         │
              └─────────┬──────────┘
                        |
                        v
              ┌────────────────────┐
              │ Feature Registry   │
              └─────────┬──────────┘
                        |
                        v
                 FEATURE SET
                        |
                        v
                    PHASE 6
```

---

# 6. Module 5.1 — Feature Inventory

Before creating anything, the system needs to understand the current features.

Example:

```text
age
sex
blood_pressure
cholesterol
glucose
bmi
heart_rate
...
```

For each feature, record:

```text
name
data type
source
range
missingness
distribution
```

Example:

```json
{
  "name": "cholesterol",
  "type": "numerical",
  "source": "original",
  "range": [100, 450],
  "transformation": "standard_scaled"
}
```

This becomes part of the **Feature Registry**.

---

# 7. Module 5.2 — Identify Feature Categories

The system classifies existing features into categories.

For example:

```text
Demographic
    age
    sex

Clinical
    blood_pressure
    glucose
    cholesterol

Lifestyle
    smoking
    alcohol

Derived
    bmi_category
```

This helps us understand the representation.

---

# 8. Module 5.3 — Candidate Feature Generation

Now we create **candidate features**.

Potential operations include:

```text
Ratios
Differences
Aggregations
Interactions
Polynomial terms
Log transformations
Binning
Domain-specific features
```

But the system should only apply operations that make sense for the dataset.

---

# 9. Example — Medical Tabular Dataset

Suppose we have:

```text
systolic_bp
diastolic_bp
height
weight
age
```

Potential engineered features:

### Pulse pressure

```text
pulse_pressure =
systolic_bp - diastolic_bp
```

### BMI

```text
BMI =
weight / height²
```

These can potentially represent clinically meaningful relationships better than the raw variables alone.

---

# 10. Example — Interaction Features

Suppose:

```text
age
cholesterol
```

We might consider:

```text
age × cholesterol
```

But we should **not automatically generate every pairwise interaction**.

If there are 100 features:

```text
100 features
→ 4,950 pairwise interactions
```

That can explode the feature space.

So candidate generation must be controlled.

---

# 11. Module 5.4 — Statistical Transformations

Some distributions may be heavily skewed.

Example:

```text
triglycerides
```

could have a long-tailed distribution.

Possible transformation:

```text
log(x)
```

or:

```text
log1p(x)
```

The system can create a candidate transformed representation.

But the transformation must be:

```text
fitted only using training data
```

to maintain the leakage rules established in Phase 4.

---

# 12. Module 5.5 — Binning

Some variables can be represented as categories.

Example:

```text
age
```

could potentially become:

```text
young
middle
older
```

However:

> We should **not automatically bin continuous medical variables**.

Binning throws away information.

It should only be considered where there is a meaningful reason.

---

# 13. Module 5.6 — Feature Interactions

Some diseases depend on combinations of variables.

For example:

```text
BMI + age
```

may carry information that neither feature captures independently.

Candidate:

```text
BMI × age
```

Again, this is a **candidate feature**, not automatically a final feature.

---

# 14. Module 5.7 — Domain-Aware Features

This is where our platform can become more than a generic AutoML pipeline.

We can eventually maintain domain-specific feature recipes.

For example:

```text
Cardiovascular
    pulse pressure
    mean arterial pressure
    BMI

Diabetes
    glucose-related ratios
    BMI-related features

Neurological
    domain-specific measurements

Imaging
    texture
    shape
    pretrained CNN embeddings
```

But there is a major rule:

> **We should never invent medical relationships simply because they improve accuracy.**

A domain feature needs either:

* established domain rationale
* dataset documentation
* literature support
* or explicit experimental labeling as a candidate

---

# 15. Important: Feature Engineering vs Feature Extraction

These are different.

### Feature Engineering

We explicitly construct features.

Example:

```text
height + weight
        ↓
BMI
```

### Feature Extraction

A model converts raw data into a representation.

Example:

```text
Skin image
     ↓
MobileNetV2
     ↓
1280-dimensional embedding
```

For our image branch, **deep feature extraction** may become important later.

---

# 16. Connection to Our Skin Cancer Idea

This connects directly to the research direction we discussed earlier.

We could have:

```text
Skin image
      ↓
CNN / pretrained backbone
      ↓
Feature embedding
      ↓
Feature reduction
      ↓
Quantum classifier
```

For example:

```text
Image
 ↓
MobileNetV2
 ↓
1280 features
 ↓
Phase 6 dimensionality reduction
 ↓
8–16 quantum-compatible features
 ↓
Quantum classifier
```

Notice:

**MobileNetV2 feature extraction can conceptually belong to Phase 5**, while the reduction to the number of features suitable for the quantum circuit belongs primarily to Phase 6.

---

# 17. Multimodal Feature Engineering

Suppose our dataset contains:

```text
Medical image
+
Patient clinical data
```

We can have:

```text
IMAGE
 ↓
CNN embedding
 ↓
image features

CLINICAL
 ↓
engineered clinical features
 ↓
clinical features

          ↓
       Fusion
          ↓
Combined representation
```

Example:

```text
Image embedding:
512 features

Clinical:
20 features

Combined:
532 features
```

Then Phase 6 can determine how to reduce/select that representation.

---

# 18. Module 5.8 — Feature Quality Evaluation

After generating candidates, we need to ask:

> **Are these features actually useful?**

Possible evaluation methods:

### Correlation

For numerical features.

### Mutual information

Measures relationship with the target.

### Statistical association

For categorical variables.

### Variance

Remove features with essentially no variation.

### Model-based importance

A baseline model can provide an initial importance signal.

But we need to be careful:

> Feature evaluation must be performed using the training data only.

Otherwise we create leakage.

---

# 19. Important: Phase 5 Does NOT Finalize Feature Selection

This is another deliberate boundary.

Suppose we have:

```text
100 candidate features
```

Phase 5 might say:

```text
Candidate features:
100

Potentially useful:
65
```

But Phase 6 decides:

> **Which features should actually enter the final representation?**

Therefore:

```text
PHASE 5
Generate + evaluate candidates

PHASE 6
Select + reduce
```

---

# 20. Feature Registry

Every generated feature should have an identity.

Example:

```text
Feature ID:
FEAT-001

Name:
pulse_pressure

Source:
systolic_bp - diastolic_bp

Type:
derived

Parent features:
systolic_bp
diastolic_bp
```

Another:

```text
Feature ID:
FEAT-002

Name:
age_cholesterol_interaction

Source:
age × cholesterol

Type:
interaction
```

This is useful for explainability later.

---

# 21. Feature Lineage

We should be able to answer:

> **"Where did this feature come from?"**

Example:

```text
pulse_pressure
      |
      ├── systolic_bp
      └── diastolic_bp
```

For image features:

```text
feature_147
      |
      └── MobileNetV2
              |
              └── image_001.jpg
```

This becomes extremely useful in Phase 12 explainability.

---

# 22. Feature Versioning

Every feature-engineering run gets an ID.

Example:

```text
FE-000001
```

So:

```text
DS-000001
   ↓
PREP-000001
   ↓
FE-000001
```

If we change the feature-generation rules:

```text
FE-000002
```

We don't overwrite the old version.

---

# 23. Example — Complete Tabular Flow

Suppose Phase 4 outputs:

```text
32 processed features
```

Phase 5 generates:

```text
Original:
32

Derived:
8

Interactions:
5

Transformations:
3

Total candidates:
48
```

Then evaluates them:

```text
48 candidate features
```

Output:

```text
Feature registry:
48 candidates
```

Phase 6 then decides which ones survive.

---

# 24. Example — Image Flow

Input:

```text
Skin image
224×224×3
```

Phase 5:

```text
Image
 ↓
Pretrained CNN
 ↓
Feature embedding
 ↓
1280-dimensional representation
```

Output:

```text
1280 candidate extracted features
```

Phase 6:

```text
1280
 ↓
selection/reduction
 ↓
16
```

Then those 16 may become suitable for a quantum model.

---

# 25. Why This Matters for QML

This is one of the most important architectural points in the entire project.

Current quantum hardware/simulators do not make it practical to directly feed:

```text
224 × 224 × 3
```

into a small quantum circuit.

That's:

```text
150,528 pixel values
```

We instead need:

```text
Image
 ↓
Classical feature extractor
 ↓
compact representation
 ↓
dimensionality reduction
 ↓
small feature vector
 ↓
quantum encoding
```

So:

> **QML does not have to replace the classical feature extractor.**

This is exactly where the hybrid architecture becomes practical.

---

# 26. But Phase 5 Does NOT Choose Qubits

Suppose we eventually want:

```text
8 qubits
```

Phase 5 should not say:

> "Therefore create exactly 8 features."

That is Phase 6.

Phase 5 creates a useful representation.

Phase 6 considers:

```text
feature usefulness
+
dimensionality
+
quantum encoding constraints
+
classical baseline requirements
```

and produces the final representations.

---

# 27. Preventing Leakage

Every feature-engineering operation that learns parameters must be fitted on training data.

For example:

```text
TRAIN
 ↓
learn transformation
 ↓
transform TRAIN

TEST
 ↓
use same transformation
```

Never:

```text
TRAIN + TEST
 ↓
learn feature transformation
```

This applies to:

* transformations
* statistical feature selection
* learned embeddings where relevant
* normalization
* dimensionality reduction

---

# 28. Feature Engineering Plan

Phase 5 should produce a **Feature Engineering Plan** before execution.

Example:

```json
{
  "feature_engineering_id": "FE-000001",

  "operations": [
    {
      "type": "derived",
      "name": "pulse_pressure",
      "formula": "systolic_bp - diastolic_bp"
    },
    {
      "type": "interaction",
      "name": "age_cholesterol",
      "formula": "age * cholesterol"
    }
  ],

  "feature_extraction": {
    "enabled": false
  }
}
```

For images:

```json
{
  "feature_engineering_id": "FE-000002",

  "feature_extraction": {
    "enabled": true,
    "backbone": "MobileNetV2",
    "output_dimension": 1280
  }
}
```

---

# 29. What Phase 5 Outputs

The main outputs are:

### 1. Feature Registry

```text
FEAT-001
FEAT-002
...
```

### 2. Feature Engineering Plan

```text
FE-000001
```

### 3. Engineered Dataset

```text
engineered/
FE-000001/
```

### 4. Feature Lineage

```text
feature → source → transformation
```

---

# 30. Example Output

```json
{
  "feature_engineering_id": "FE-000001",

  "dataset_id": "DS-000001",

  "input_pipeline": "PREP-000001",

  "input_features": 32,

  "candidate_features": 48,

  "operations": [
    "derived_features",
    "interaction_features"
  ],

  "feature_registry": "...",

  "status": "ENGINEERED",

  "next_phase": "FEATURE_SELECTION"
}
```

---

# 31. What Phase 5 Does NOT Do

It does **not**:

* choose the final feature subset
* decide the final number of qubits
* choose VQC/QSVM/QNN
* train quantum models
* train classical models for final benchmarking
* compare quantum vs classical
* perform final dimensionality reduction
* calculate quantum cost

Those happen later.

---

# 32. Phase 5 Architecture

```text
                    PROCESSED DATA
                           |
                           v
                 ┌──────────────────┐
                 │ Feature Analyzer │
                 └────────┬─────────┘
                          |
                          v
                 ┌──────────────────┐
                 │ Candidate        │
                 │ Generator        │
                 └────────┬─────────┘
                          |
             ┌────────────┼────────────┐
             ↓            ↓            ↓
          Derived     Interaction   Transform
          Features     Features     Features
             |            |            |
             └────────────┼────────────┘
                          ↓
                 ┌──────────────────┐
                 │ Feature Quality  │
                 │ Evaluation       │
                 └────────┬─────────┘
                          |
                          v
                 ┌──────────────────┐
                 │ Feature Registry │
                 └────────┬─────────┘
                          |
                          v
                  FEATURE SET
                          |
                          v
                       PHASE 6
```

For imaging:

```text
IMAGE
  ↓
Feature Extractor
  ↓
CNN / pretrained backbone
  ↓
Embedding
  ↓
Feature Registry
  ↓
PHASE 6
```

---

# 33. Phase 5 Success Criteria

Phase 5 is complete when we can:

* [ ] Build a feature inventory
* [ ] Track feature metadata
* [ ] Generate appropriate derived features
* [ ] Generate controlled interaction features
* [ ] Apply justified transformations
* [ ] Support domain-aware feature generation
* [ ] Support image feature extraction where required
* [ ] Evaluate candidate feature usefulness
* [ ] Maintain feature lineage
* [ ] Version feature-engineering runs
* [ ] Prevent feature-engineering leakage
* [ ] Produce a reproducible feature-engineering plan
* [ ] Produce an engineered feature representation
* [ ] Hand off candidate features to Phase 6

---

# 34. The First Five Phases

We now have:

```text
PHASE 1
"What did you give us?"
        ↓
INGESTION

PHASE 2
"What is inside it?"
        ↓
PROFILING

PHASE 3
"Can we use it?"
        ↓
VALIDATION

PHASE 4
"How do we clean/prepare it?"
        ↓
PREPROCESSING

PHASE 5
"How can we represent useful information?"
        ↓
FEATURE ENGINEERING

PHASE 6
"Which representation should actually go
into our models?"
```

And **Phase 6 is where the QML-specific problem starts becoming much more central**: we will need to decide how to reduce/select the feature space while keeping a fair representation for both the classical and quantum branches.
